Cell and Gene Therapy, Industry
May 20, 2022
Via: FierceBiotechBayer is pulling the plug on its $670 million CAR-T pact with Atara Biotherapeutics. Three months after a death paused a study of the lead candidate, the German drugmaker has decided to cut its ties to Atara’s two mesothelin-directed CAR-T […]
July 19, 2024
July 11, 2024
July 11, 2024